These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

327 related items for PubMed ID: 28576479

  • 21. Longitudinal analysis of quality of life, clinical, radiographic, echocardiographic, and laboratory variables in dogs with myxomatous mitral valve disease receiving pimobendan or benazepril: the QUEST study.
    Häggström J, Boswood A, O'Grady M, Jöns O, Smith S, Swift S, Borgarelli M, Gavaghan B, Kresken JG, Patteson M, Åblad B, Bussadori CM, Glaus T, Kovačević A, Rapp M, Santilli RA, Tidholm A, Eriksson A, Belanger MC, Deinert M, Little CJ, Kvart C, French A, Rønn-Landbo M, Wess G, Eggertsdottir A, Lynne O'Sullivan M, Schneider M, Lombard CW, Dukes-McEwan J, Willis R, Louvet A, DiFruscia R.
    J Vet Intern Med; 2013; 27(6):1441-51. PubMed ID: 24010489
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Renin-angiotensin aldosterone profile before and after angiotensin-converting enzyme-inhibitor administration in dogs with angiotensin-converting enzyme gene polymorphism.
    Adin D, Atkins C, Domenig O, DeFrancesco T, Keene B, Tou S, Stern JA, Meurs KM.
    J Vet Intern Med; 2020 Mar; 34(2):600-606. PubMed ID: 32112596
    [Abstract] [Full Text] [Related]

  • 24. Combined use of renin-angiotensin-aldosterone system-acting agents: a cross-sectional study.
    Farcas A, Leucuta D, Bucsa C, Mogosan C, Dumitrascu D.
    Int J Clin Pharm; 2016 Dec; 38(6):1390-1397. PubMed ID: 27677980
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Evaluation of the effect of an angiotensin-converting enzyme inhibitor, alacepril, on drug-induced renin-angiotensin-aldosterone system activation in normal dogs.
    Sakatani A, Miyagawa Y, Takemura N.
    J Vet Cardiol; 2016 Sep; 18(3):248-254. PubMed ID: 27364087
    [Abstract] [Full Text] [Related]

  • 27. Changes in renin-angiotensin-aldosterone system during cardiac remodeling after mitral valvuloplasty in dogs.
    Cheng CJ, Mandour AS, Yoshida T, Watari T, Tanaka R, Matsuura K.
    J Vet Intern Med; 2022 Mar; 36(2):397-405. PubMed ID: 34994485
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Pharmacodynamic assessment of diuretic efficacy and braking in a furosemide continuous infusion model.
    Adin D, Atkins C, Papich MG.
    J Vet Cardiol; 2018 Apr; 20(2):92-101. PubMed ID: 29483040
    [Abstract] [Full Text] [Related]

  • 31. Capturing the dynamics of systemic Renin-Angiotensin-Aldosterone System (RAAS) peptides heightens the understanding of the effect of benazepril in dogs.
    Mochel JP, Peyrou M, Fink M, Strehlau G, Mohamed R, Giraudel JM, Ploeger B, Danhof M.
    J Vet Pharmacol Ther; 2013 Apr; 36(2):174-80. PubMed ID: 22568394
    [Abstract] [Full Text] [Related]

  • 32. The renin-angiotensin-aldosterone system and its suppression.
    Ames MK, Atkins CE, Pitt B.
    J Vet Intern Med; 2019 Mar; 33(2):363-382. PubMed ID: 30806496
    [Abstract] [Full Text] [Related]

  • 33. Temporal changes in clinical and radiographic variables in dogs with preclinical myxomatous mitral valve disease: The EPIC study.
    Boswood A, Gordon SG, Häggström J, Vanselow M, Wess G, Stepien RL, Oyama MA, Keene BW, Bonagura J, MacDonald KA, Patteson M, Smith S, Fox PR, Sanderson K, Woolley R, Szatmári V, Menaut P, Church WM, O'Sullivan ML, Jaudon JP, Kresken JG, Rush J, Barrett KA, Rosenthal SL, Saunders AB, Ljungvall I, Deinert M, Bomassi E, Estrada AH, Fernandez Del Palacio MJ, Moise NS, Abbott JA, Fujii Y, Spier A, Luethy MW, Santilli RA, Uechi M, Tidholm A, Schummer C, Watson P.
    J Vet Intern Med; 2020 May; 34(3):1108-1118. PubMed ID: 32200574
    [Abstract] [Full Text] [Related]

  • 34. Chronobiology and Pharmacologic Modulation of the Renin-Angiotensin-Aldosterone System in Dogs: What Have We Learned?
    Mochel JP, Danhof M.
    Rev Physiol Biochem Pharmacol; 2015 May; 169():43-69. PubMed ID: 26428686
    [Abstract] [Full Text] [Related]

  • 35. Effect of renin-angiotensin-aldosterone system triple blockade on non-diabetic renal disease: addition of an aldosterone blocker, spironolactone, to combination treatment with an angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker.
    Furumatsu Y, Nagasawa Y, Tomida K, Mikami S, Kaneko T, Okada N, Tsubakihara Y, Imai E, Shoji T.
    Hypertens Res; 2008 Jan; 31(1):59-67. PubMed ID: 18360019
    [Abstract] [Full Text] [Related]

  • 36. Determinants of increased angiotensin II levels in severe chronic heart failure patients despite ACE inhibition.
    van de Wal RM, Plokker HW, Lok DJ, Boomsma F, van der Horst FA, van Veldhuisen DJ, van Gilst WH, Voors AA.
    Int J Cardiol; 2006 Jan 26; 106(3):367-72. PubMed ID: 16337046
    [Abstract] [Full Text] [Related]

  • 37. Impact of a combination of pimobendan, furosemide, and enalapril on heart rate variability in naturally occurring, symptomatic, myxomatous mitral valve degeneration dogs.
    Pirintr P, Saengklub N, Boonpala P, Hamlin RL, Kijtawornrat A.
    BMC Vet Res; 2023 Oct 12; 19(1):201. PubMed ID: 37821927
    [Abstract] [Full Text] [Related]

  • 38. Left Atrial Strain at Different Stages of Myxomatous Mitral Valve Disease in Dogs.
    Nakamura K, Kawamoto S, Osuga T, Morita T, Sasaki N, Morishita K, Ohta H, Takiguchi M.
    J Vet Intern Med; 2017 Mar 12; 31(2):316-325. PubMed ID: 28145607
    [Abstract] [Full Text] [Related]

  • 39. Effects of naturally acquired decompensated mitral valve regurgitation on the renin-angiotensin-aldosterone system and atrial natriuretic peptide concentration in dogs.
    Häggström J, Hansson K, Kvart C, Karlberg BE, Vuolteenaho O, Olsson K.
    Am J Vet Res; 1997 Jan 12; 58(1):77-82. PubMed ID: 8989501
    [Abstract] [Full Text] [Related]

  • 40. Associations among serum N-terminal procollagen type III concentration, urinary aldosterone-to-creatinine ratio, and ventricular remodeling in dogs with myxomatous mitral valve disease.
    Hezzell MJ, Boswood A, Chang YM, Moonarmart W, Elliott J.
    Am J Vet Res; 2012 Nov 12; 73(11):1765-74. PubMed ID: 23106462
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.